Ulf Hannelius

All filings by Ulf Hannelius on record concern Diamyd Medical Aktiebolag. Over a trading history stretching from 6 April 2017 to 29 April 2025, the count stands at 23 filings.

In open-market terms, that means 13 purchases worth €104k on one side and 1 sale worth €41k on the other. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The median purchase comes to €7,299. Clusters matter here: 1 out of 10 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 30 April 2025: a transaction of €67k, in Diamyd Medical Aktiebolag. The latest purchase dates back some time: it was published 782 days ago, on 2 September 2024. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.